STÁREK, Zdeněk, František LEHAR, Jiří JEŽ, Jiří WOLF and Miroslav NOVÁK. Hybrid therapy in the management of atrial fibrillation. Current Cardiology Reviews. San Francisco: Bentham Science Publishers B.V., 2015, vol. 11, No 2, p. 167-179. ISSN 1573-403X. Available from: https://dx.doi.org/10.2174/1573403X10666140713172231.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Hybrid therapy in the management of atrial fibrillation
Authors STÁREK, Zdeněk (203 Czech Republic, guarantor, belonging to the institution), František LEHAR (203 Czech Republic, belonging to the institution), Jiří JEŽ (203 Czech Republic, belonging to the institution), Jiří WOLF (203 Czech Republic, belonging to the institution) and Miroslav NOVÁK (203 Czech Republic, belonging to the institution).
Edition Current Cardiology Reviews, San Francisco, Bentham Science Publishers B.V. 2015, 1573-403X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/15:00082500
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.2174/1573403X10666140713172231
UT WoS 000212845800011
Keywords in English Atrial fibrillation; catheter ablation of arrhythmias; pharmacological antiarrhythmic therapy; hybrid therapy
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 2/3/2016 12:24.
Abstract
Atrial fibrillation is the most common sustained arrhythmia. Because of the sub-optimal outcomes and associated risks of medical therapy as well as the recent advances in non-pharmacologic strategies, a multitude of combined (hybrid) algorithms have been introduced that improve efficacy of standalone therapies while maintaining a high safety profile. Antiarrhythmic administration enhances success rate of electrical cardioversion. Catheter ablation of antiarrhythmic drug-induced typical atrial flutter may prevent recurrent atrial fibrillation. Through simple ablation in the right atrium, suppression of atrial fibrillation may be achieved in patients with previously ineffective antiarrhythmic therapy. Efficacy of complex catheter ablation in the left atrium is improved with antiarrhythmic drugs. Catheter ablation followed by permanent pacemaker implantation is an effective and safe treatment option for selected patients. Additional strategies include pacing therapies such as atrial pacing with permanent pacemakers, preventive pacing algorithms, and/or implantable dual-chamber defibrillators are available. Modern hybrid strategies combining both epicardial and endocardial approaches in order to create a complex set of radiofrequency lesions in the left atrium have demonstrated a high rate of success and warrant further research. Hybrid therapy for atrial fibrillation reviews history of development of non-pharmacological treatment strategies and outlines avenues of ongoing research in this field.
PrintDisplayed: 23/6/2024 00:45